Evidence map›Paper›PMID 37386080›Full record

ArticleLeukemia2023

The recombinome of IKZF1 deletions in B-cell precursor ALL.

Bruno A Lopes, Claus Meyer, Heloysa Bouzada, Marius Külp, Ana Luiza Tardem Maciel, Patrizia Larghero, Thayana C Barbosa, Caroline P Poubel, Caroline Barbieri, Nicola C Venn and 14 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Leukemia, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Bruno A LopesProgram of Molecular Carcinogenesis and Division of Clinical Research, Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA), Rio de Janeiro, Brazil. blopes@inca.gov.br.ORCID 0000-0003-1072-470X
Claus MeyerDCAL, Institute of Pharmaceutical Biology, Goethe-University, Frankfurt/Main, Germany.
Heloysa BouzadaProgram of Molecular Carcinogenesis and Division of Clinical Research, Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA), Rio de Janeiro, Brazil.
Marius KülpDCAL, Institute of Pharmaceutical Biology, Goethe-University, Frankfurt/Main, Germany.ORCID 0000-0002-6594-8412
Ana Luiza Tardem MacielProgram of Molecular Carcinogenesis and Division of Clinical Research, Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA), Rio de Janeiro, Brazil.
Patrizia LargheroDCAL, Institute of Pharmaceutical Biology, Goethe-University, Frankfurt/Main, Germany.
Thayana C BarbosaProgram of Molecular Carcinogenesis and Division of Clinical Research, Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA), Rio de Janeiro, Brazil.
Caroline P PoubelProgram of Molecular Carcinogenesis and Division of Clinical Research, Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA), Rio de Janeiro, Brazil.
Caroline BarbieriProgram of Molecular Carcinogenesis and Division of Clinical Research, Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA), Rio de Janeiro, Brazil.
Nicola C VennMolecular Diagnostics, Children's Cancer Institute, Lowy Cancer Research Centre, UNSW, Sydney, NSW, Australia.
Luciano Dalla PozzaCancer Centre for Children, The Children's Hospital at Westmead, Sydney, NSW, Australia.
Draga BarbaricSydney Children's Hospital, Randwick, NSW, Australia.
Chiara PalmiTettamanti Cente, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
Grazia FazioTettamanti Cente, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.ORCID 0000-0001-7077-8422
Claudia SaittaTettamanti Cente, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.ORCID 0000-0002-5842-7774
Thais F AguiarArthur Siqueira Cavalcanti Hematology Institute (HEMORIO), Rio de Janeiro, Brazil.
Mecneide M LinsInstituto de Medicina Integral Prof. Fernando Figueira (IMIP), Recife, Brazil.
Maura R V Ikoma-ColturatoHospital Amaral Carvalho, São Paulo, Brazil.ORCID 0000-0002-1473-9696
Marcia SchrammProntobaby Hospital da Criança, Rio de Janeiro, Brazil.
Eduardo ChapchapHospital Israelita Albert Einstein, São Paulo, Brazil.
Gianni CazzanigaTettamanti Cente, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
Rosemary SuttonMolecular Diagnostics, Children's Cancer Institute, Lowy Cancer Research Centre, UNSW, Sydney, NSW, Australia.ORCID 0000-0002-0188-6005
Rolf MarschalekDCAL, Institute of Pharmaceutical Biology, Goethe-University, Frankfurt/Main, Germany.ORCID 0000-0003-4870-3445
Mariana EmerencianoProgram of Molecular Carcinogenesis and Division of Clinical Research, Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA), Rio de Janeiro, Brazil. memerenciano@inca.gov.br.ORCID 0000-0003-2337-8420

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Precursor B-Cell Lymphoblastic Leukemia-LymphomaTranscription FactorsGene DeletionHumansIkaros Transcription FactorPrognosisIkaros Transcription FactorIKZF1 protein, humanTranscription Factors

Identifiers

PMID37386080

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.